Literature DB >> 17947715

Obesity in dose calculation: a mouse or an elephant?

Howard Gurney, Rachel Shaw.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17947715     DOI: 10.1200/JCO.2007.13.1078

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review.

Authors:  Weixin Wu; Xiandong Liu; Patrick Chaftari; Maria Teresa Cruz Carreras; Carmen Gonzalez; Jayne Viets-Upchurch; Kelly Merriman; Shi-Ming Tu; Shalini Dalal; Sai-Ching J Yeung
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

2.  Ultra-High-Precision, in-vivo Pharmacokinetic Measurements Highlight the Need for and a Route Toward More Highly Personalized Medicine.

Authors:  Philip A Vieira; Christina B Shin; Netzahualcóyotl Arroyo-Currás; Gabriel Ortega; Weiwei Li; Arturo A Keller; Kevin W Plaxco; Tod E Kippin
Journal:  Front Mol Biosci       Date:  2019-08-16

3.  Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.

Authors:  Pernille Rudebeck Mogensen; Kathrine Grell; Kjeld Schmiegelow; Ulrik Malthe Overgaard; Benjamin Ole Wolthers; Signe Sloth Mogensen; Allan Vaag; Thomas Leth Frandsen
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

4.  Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma.

Authors:  Junjun Mao; Qing Li; Pei Li; Weiwei Qin; Bobin Chen; Mingkang Zhong
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.